Insiders · ADXS

ADXS insider transactions

Advaxis, Inc. (ADXS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ADXS

• 819d
  SEC Form 4 filed by Israel Biotech Fund I, L.P.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 842d
  Israel Biotech Fund I, L.P. exercised 27,847,159 shares at a strike of $0.40 and covered exercise/tax liability with 5,294,486 shares (SEC Form 4)

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 925d
  SEC Form 4 filed by Israel Biotech Fund I, L.P.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 938d
  New insider Cabilly Yuval claimed ownership of 1,298,639 shares (SEC Form 3)

  3 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 943d
  SEC Form 3 filed by new insider Golan Roy (Amendment)

  3/A - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 943d
  SEC Form 3 filed by new insider Orbach Pini (Amendment)

  3/A - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 943d
  SEC Form 3 filed by new insider Martell Bridget A (Amendment)

  3/A - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 946d
  Israel Biotech Fund I, L.P. bought 1,317,716 shares (SEC Form 4)

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 954d
  Amoon Growth Fund Limited Partnership disposed of 0 shares (SEC Form 4)

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 978d
  SEC Form 4 filed by Israel Biotech Fund I, L.P. (Amendment)

  4/A - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 978d
  New insider Israel Biotech Fund I, L.P. claimed ownership of 621,253 shares (SEC Form 3) (Amendment)

  3/A - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 996d
  SEC Form 4 filed by Israel Biotech Fund I, L.P.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 996d
  SEC Form 3: New insider Israel Biotech Fund I, L.P. claimed ownership of 621,253 shares

  3 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1220d
  SEC Form 3: New insider Amoon Growth Fund Limited Partnership claimed ownership of 560,602 shares

  3 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4: Sidransky David was granted 46 shares

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4 filed by Goldberg Murray A

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 3 filed by new insider Goldberg Murray A

  3 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 3 filed by new insider Bisker-Leib Vered

  3 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 3 filed by new insider Spiegel Robert J.

  3 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1933d
  SEC Form 3 filed by Igor Gitelman

  3 - Advaxis, Inc. (0001100397) (Issuer)